Antithymocyte globulins in renal transplantation-from lymphocyte depletion to lymphocyte activation: The doubled-edged sword
Affiliation auteurs | !!!! Error affiliation !!!! |
Titre | Antithymocyte globulins in renal transplantation-from lymphocyte depletion to lymphocyte activation: The doubled-edged sword |
Type de publication | Journal Article |
Year of Publication | 2017 |
Auteurs | Bamoulid J, Crepin T, Courivaud C, Rebibou J-M, Saas P, Ducloux D |
Journal | TRANSPLANTATION REVIEWS |
Volume | 31 |
Pagination | 180-187 |
Date Published | JUL |
Type of Article | Article |
ISSN | 0955-470X |
Résumé | Compelling data suggest that lymphocyte depletion following T cell depleting therapy may induce prolonged CD4 T cell lymphopenia and trigger lymphocyte activation in some patients. These profound and non-reversible immune changes in T cell pool subsets are the consequence of both impaired thymic renewal and peripheral homeostatic proliferation. Chronic viral challenges by CMV play a major role in these immune alterations. Even when the consequences of CD4 T cell lymphopenia have been now well described, recent studies shed new light on the clinical consequences of immune activation. In this review, we will first focus on the mechanisms involved in T cell pool reconstitution after T cell depletion and further consider the clinical consequences of ATG-induced T cell activation and senescence in renal transplant recipients. (C) 2017 Elsevier Inc. All rights reserved. |
DOI | 10.1016/j.trre.2017.02.004 |